Unlikely to cause harm — often a labeling or packaging issue.
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
| Brand name | PANTOPRAZOLE SODIUM |
| Generic name | PANTOPRAZOLE SODIUM |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Distributed by / for | Aurobindo Pharma USA Inc |
| NDC | 55150-202-00 |
| Full product label | Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00 |
| Recalling firm | Aurobindo Pharma USA Inc |
| Distribution | Nationwide in US |
| Quantity | 29800 vials |
| Recall initiated | 2016-12-16 |
| Report date | 2017-02-15 |
| Recall completed | 2020-07-29 |
| Recall number | D-0470-2017 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Plainsboro NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗